AI in Medical Affairs team

AI-Powered Medical Affairs: Enhancing value, engagement, and insights

The pharmaceutical sector is witnessing a transformative shift fueled by the…


HCPs, PAOs and Pharmaceutical Funding

Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding

The entanglement of financial relationships among healthcare professionals…


New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis

The overuse and misuse of antimicrobials in humans and animals have escalated…


How Education can serve as a catalyst for wider Biosimilar Adoption.

Even two decades after their introduction, the global adoption rate of…


Biosimilar Landscape in 2024

Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond

The anticipated expiration of exclusivity rights for major biologics in 2022…


Pharma and Longevity

The Next Frontier: Pharma and Longevity

From The Epic of Gilgamesh, the earliest surviving book, to the controversial…


Personalised mRNA cancer vaccines

mRNA personalized Cancer Vaccines: BioNTech and Moderna Race to the Finish Line

With the emergence of immunotherapy for oncology, cancer vaccines are cropping…


Cell and Gene Therapy Clinical Trials lansdcape 2023 Edition.

Cell and Gene Therapy Clinical Trials – 2024 Edition 

Gene therapy clinical trials promise transformative breakthroughs in treating…


Navigating the Immunoglobulin Therapy Landscape: An Overview

The Immunoglobulin Replacement Therapy (IG) market is growing, as these…


Digital vaccines against lifestyle diseases

Can "Digital Vaccines" be a game-changer in lifestyle diseases?

Digital vaccines are clinically proven  "no injection, no ingestion" vaccines.…


RSV vaccines

RSV vaccines: A powerful tool to protect against RSV 

According tο a recent systematic analysis focusing on children younger than…